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In the past two decades, two other coronaviruses that cause severe respiratory illness in humans 117 have emerged: severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East 118 respiratory syndrome coronavirus (MERS-CoV). With the emergence of SARS-CoV-2, a third 119 coronavirus that can cause severe respiratory illness has been identified. In a short period of 120 time, this novel coronavirus has caused more cases of illness than were reported for MERS and 121 SARS combined. Here we summarize what is currently known about COVID-19and what this 122 means for practicing obstetricians and their pregnant patients. Since so little is currently known 123 about COVID-19 in pregnancy, we also review available information on the effects of SARS and 124 MERS during pregnancy to inform care of pregnant women with COVID-19 until additional data 125 on pregnant women and their fetuses become available.
The natural reservoir for SARS-CoV is believed to be bats; however, some evidence 138 supported civet cats or raccoon dogs as possible intermediate sources of these illnesses. 8 SARS is 139 transmitted by close person-to-person contact through contact of the mucus membranes of the 140 respiratory tract with respiratory droplets formed when an infected person coughs or sneezes. 141 Fecal-oral transmission and transmission via fomites have also been reported. 8 Airborne spread 142 due to inhalation of small particle aerosols may also be possible. Transmission in health care 143 settings was frequently seen during the 2003 outbreak, with superspreading (when a single 144 patient transmits infection to a disproportionate number of contacts) reported. 9 The incubation 145 period was estimated at a mean of 4.6 days, with a range of 2-14 days. Transmission appeared to 146 occur most often during the second week of illness when viral excretion is highest; there is no 147 evidence that a person with SARS is contagious before symptom onset. 148 The largest case series of pregnant women with SARS was from the 2003 outbreak in 149 Hong Kong, in which 12 pregnant women were identified. 10 The case-fatality rate was 25% (3 150 deaths). Clinical and laboratory findings were similar to those seen in the non-pregnant 151 population. Pneumonia on chest radiograph or CT was seen in all patients. Major medical 152 complications included adult respiratory distress syndrome in four, disseminated intravascular 153 coagulopathy (DIC) in three, renal failure in three, secondary bacterial pneumonia in two, and 154 sepsis in two patients.
155
Pregnancy outcomes varied by trimester of presentation. 10 Among the seven women who 156 became ill in the first trimester, four had a spontaneous abortion, two had pregnancy terminations 157 for social reasons after recovery from SARS, and one delivered a full-term healthy infant.
158
Among the five women who presented after 24 weeks gestation, four delivered preterm. Three 159 women delivered by cesarean delivery due to deteriorating maternal condition from their SARS 160 illness at 26, 28 and 32 weeks gestation. 11 These babies had birth weights appropriate for 161 gestational age. Two of the infants had respiratory distress syndrome requiring surfactant (born 162 at 26 and 28 weeks gestation), with one later developing bronchopulmonary dysplasia.
163
Gastrointestinal complications were observed in two infants, including a jejunal perforation in an 164 infant delivered at 26 weeks and necrotizing enterocolitis with ileal perforation in an infant 165 delivered at 28 weeks gestation. Whether these gastrointestinal complications were related to 166 complications from SARS or its treatment or if they were secondary to preterm delivery is 167 unknown. 11 The two infants who were delivered after their mothers' recovery from SARS had 168 intrauterine growth restriction. No clinical, radiologic, or laboratory evidence for transmission 169 from mother to fetus was observed, despite laboratory testing of different specimens. 12, 13 
170
A matched case-control study 14 compared 10 of the 12 pregnant women noted above (two 171 were excluded because they were unable to be matched) to 40 non-pregnant women with SARS.
172
Women were matched on sex, age, timing of contracting SARS, health care worker status, 173 underlying illness and whether the woman resided in a housing area where there was a large 174 outbreak. Pregnancy appeared to have no effect on clinical symptoms or time to presentation 175 after symptom onset. However, complications and adverse outcomes were more common among 176 pregnant women: women who were pregnant had a longer hospital stay, were statistically 177 significantly more likely to develop renal failure, sepsis, and DIC, and were more likely to 178 require intensive care unit admission. Forty percent of pregnant women required mechanical 179 ventilation, compared to 13% of non-pregnant patients (p=0.07). Pregnant women were also 180 significantly more likely to die (p=0.01). 181 We identified five reports of additional cases of SARS during pregnancy treated in Hong 182 Kong (n=2), United States (n=2), and Canada (n=1). [15] [16] [17] [18] [19] Two of the five women required mechanical ventilation, one required hemodialysis for acute renal failure, and one had seizures 184 and positive cerebrospinal fluid for SARS-CoV, suggestive of a central nervous system infection.
185
All patients recovered from their illness. In one case, the pregnancy was terminated at the 186 mother's request; the remaining pregnancies ended in liveborn infants (two at term and two 187 preterm). Testing of neonatal specimens for SARS-CoV RNA was negative. The SARS-CoV-2 is a betacoronavirus similar to SARS-CoV and MERS-CoV (Table) . 247 Sequencing data show that the SARS-CoV-2 is most closely related to coronaviruses found in 248 bats, with more than 85% nucleotide identity with a bat SARS-like CoV. 34, 35 The virus has 79% 249 nucleotide identity to SARS-CoV and about 50% to MERS-CoV. 35 Bats appear to be the natural feet. It is unclear if infection can be transmitted from fomites. Fecal-oral transmission might be 273 possible, given that SARS-CoV-2 has been identified in stool specimens 40 and SARS-CoV might 274 have been transmitted in this manner. 41 The basic reproduction number, R0 (the average number Implications of COVID-19 for pregnant women 285 In the midst of a rapidly evolving outbreak that could have significant effects on our 286 public health and medical infrastructure, the unique needs of pregnant women should be included 287 in preparedness and response plans. In previous outbreaks, clinicians have at times been reluctant 288 to treat or vaccinate pregnant women because of concerns for fetal safety. 43 It is critical that 289 pregnant women not be denied potentially life-saving interventions in the context of a serious 290 infectious disease threat unless there is a compelling reason to exclude them. As with all 291 decisions regarding treatment during pregnancy, carefully weighing of the benefits of 292 interventions for the mother and fetus with potential risks is necessary. As surveillance systems 293 for cases of COVID-19 are established, it is essential that information on pregnancy status, as 294 well as maternal and fetal outcomes, be collected and reported.
295
Travel guidance for pregnant women 319 Travel recommendations have been instituted to limit exposure to persons in the United centers that have experience with this technique. 47 Whether delivery provides benefit to a 365 critically ill mother is unknown; decisions regarding delivery should consider the gestational age 366 of the fetus and should be made in conjunction with the neonatologist. 48 
367
There are currently no antiviral medications approved by the US Food and Drug Consider early mechanical ventilation with evidence of advancing respiratory failure. Non-invasive ventilation techniques may have a small increased risk of aspiration in pregnancy. • Use intravenous fluids conservatively unless cardiovascular instability is present.
• Screen for other viral respiratory infections and bacterial infections (due to risk of coinfections). • Consider empiric antimicrobial therapy (because of risk for superimposed bacterial infections). • Consider empiric treatment for influenza, pending diagnostic testing.
• Do not routinely use corticosteroids. Use of steroids to promote fetal maturity with anticipated preterm delivery can be considered on individual basis. • If septic shock is suspected, institute prompt, targeted management.
• Delivery and pregnancy termination decisions should be based on gestational age, maternal condition, and fetal stability, and maternal wishes. • Consult with specialists in obstetrics, maternal-fetal medicine, neonatology, intensive care, anesthesia, and nursing. • Communicate with patients and families regarding diagnosis, clinical status and management wishes.
*All guidance should be considered subject to revision as additional data on pregnant women with COVID-19 become available. 
